In the News | Friends of Cancer Research

You are here

In the News

May 25, 2020
The desire to pursue a career in medicine took root when Lori J. Pierce, MD, FASTRO, FASCO, was a young child visiting family in segregated Ahoskie, North Carolina. She witnessed firsthand the impact... Read more
May 25, 2020
The Reagan-Udall Foundation for the U.S. Food and Drug Administration (FDA) in collaboration with Friends of Cancer Research recently announced the COVID-19 Evidence Accelerator, an expansive public-... Read more
May 22, 2020
Executive Summary FDA's Amy Abernethy tells the Pink Sheet that initial priorities are likely to include studying COVID-19 natural history and how patients are faring under various medication... Read more
May 21, 2020
The FDA has entered an agreement with healthcare analytics company Aetion to research urgent questions about COVID-19.   The New York City-based company said the research will support FDA objectives... Read more
May 21, 2020
International regulators will increase cooperation for observational studies conducted in three key eras during the coronavirus pandemic.Building a strong infrastructure to monitor vaccine safety and... Read more
May 21, 2020
FDA this week announced a project with health tech company Aetion to track and analyze Covid-19 treatments and diagnostics in a bid to better understand what works — and what doesn’t.   The new... Read more
May 19, 2020
The Food and Drug Administration said Tuesday that it will launch a new research project focused on real-world evidence — data collected by insurance companies, in electronic health records, and in... Read more
May 19, 2020
The FDA said Tuesday it’s pairing up with the data company Aetion to research Covid-19 complications and what types of medicines virus patients are taking, which could help researchers learn more... Read more
May 19, 2020
The US Food and Drug Administration (FDA) on Tuesday said it will partner with New York-based health technology firm Aetion, Inc. to develop real-world data analytics to answer pressing questions... Read more
May 14, 2020
Michelle McMurry-Heath doesn’t talk about biotech the way her peers do.   Where other executives and experts might bring up “access,” and “reimbursement,” McMurry-Heath talks about fairness and... Read more

Pages